PHILLIP M. RENFRO

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ENZON PHARMACEUTICALS, INC.

Filing Date Source Excerpt
2006-04-12 Phillip M. Renfro, age 60, has served as a director of the Company since January 2005. ... The Finance and Audit Committee currently consists of Messrs. Salisbury (Chairman), Classon, LeBuhn and Renfro. ... The Governance and Nominating Committee currently consists of Messrs. Renfro (Chairman), Micati and Salisbury. ... During the fiscal year ended June 30, 2005, the Company recorded the following fees earned: Phillip Renfro $46,140 cash compensation ...
2007-04-10 Phillip M. Renfro, age 61, has served as a director of the Company since January 2005. ... The Finance and Audit Committee currently consists of Messrs. Salisbury (Chairman), Classon, LeBuhn and Renfro. ... The Governance and Nominating Committee currently consists of Messrs. Micati (Chairman), Renfro, LeBuhn and Salisbury. ... The Compensation Committee currently consists of Dr. Ando (Chairman) and Messrs. Classon and Micati. ... Director Compensation for fiscal year ended December 31, 2006: Phillip Renfro total $136,313.
2008-04-16 Phillip M. Renfro, age 62, has served as a director of the Company since January 2005... The Finance and Audit Committee currently consists of Messrs. Salisbury (Chairman), Classon, LeBuhn and Renfro... The Governance and Nominating Committee currently consists of Messrs. Micati (Chairman), Renfro, LeBuhn and Salisbury... Director compensation for fiscal year ended December 31, 2007: Phillip Renfro total $149,749.

Data sourced from SEC filings. Last updated: 2025-08-30